4 offerings have no amendment in the last 12 months and may still be open
No amendment in the last 12 months on an offering that may still be open — Garuda Therapeutics, Inc. (latest filing Oct 31, 2024) · No amendment in the last 12 months on an offering that may still be open — Garuda Therapeutics, Inc. (latest filing Feb 3, 2023) · No amendment in the last 12 months on an offering that may still be open — Garuda Therapeutics, Inc. (latest filing Sep 24, 2021) · No amendment in the last 12 months on an offering that may still be open — Virdante Pharmaceuticals, Inc. (latest filing Oct 14, 2011)
What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.
Sources
- Form D · Oct 31, 2024 ↗ (Oct 31, 2024)
- Garuda Therapeutics, Inc. — PartnerFacts page ↗ (Oct 31, 2024)
- Form D · Feb 3, 2023 ↗ (Feb 3, 2023)
- Form D · Sep 24, 2021 ↗ (Sep 24, 2021)
- Form D/A · Oct 14, 2011 ↗ (Oct 14, 2011)
- Virdante Pharmaceuticals, Inc. — PartnerFacts page ↗ (Oct 14, 2011)